The ARF GTPase Activating Protein 1 (ARFGAP1) associates mainly with the cytosolic side of Golgi cisternal membranes where it participates in the formation of both COPI and clathrin-coated vesicles. In this study, we show that ARFGAP1 associates transiently with lipid droplets upon addition of oleate in cultured cells. Also, that addition of cyclic AMP shifts ARFGAP1 from lipid droplets to the Golgi apparatus and that overexpression and knockdown of ARFGAP1 affect lipid droplet formation. Examination of human liver tissue reveals that ARFGAP1 is found associated with lipid droplets at steady state in some but not all hepatocytes.
Introduction
Both genetics-and cell biology-based experiments link COPI coat components including the small GTPase, ARF1, coatomer and the exchange factor, GBF1 to lipid droplet biogenesis [1] [2] [3] [4] [5] . ARF1 is one of 5 ARFs associated with the Golgi apparatus (for review, see [6] ) and through GTP hydrolysis catalyzed by an ARF GTP Activating Protein (ARFGAP), regulates COPI coat formation [7] [8] [9] and sorting of proteins into COPI vesicles [10] [11] [12] . ARF1 is also linked to recruitment of lipid modifying enzymes such as phospholipase D (PLD1) [13, 14] and phosphoinositol kinases [15] to Golgi membranes as well as GGA proteins involved in clathrin-coated vesicle formation from Golgi membranes [16, 17] . In addition, ARF1 regulates association of adipocyte differentiation-related protein (ADRP, PLIN2) and PLD1 on the cytosolic leaflet of lipid droplets [18, 19] . ARF1 function is regulated by the exchange of bound GDP for GTP via an exchange factor (e.g. GBF1) transitioning ARF1 from an inactive to an active conformation. This is then followed by hydrolysis of bound GTP to GDP transitioning ARF1 back to an inactive conformation. Due to its intrinsically low GTP hydrolysis rate, ARF1 requires an activating protein for GTP hydrolysis. In mammalian cells, three related activating proteins termed ARFGAP1-3 are linked to COPI vesicle formation through ARF of which ARFGAP1 is the prototypical protein. Of the three, ARFGAP1 appears sensitive to both membrane lipid composition [20, 21] and membrane curvature [22, 23] and has also been proposed to act as a structural component alongside coatomer to form the COPI coat [24, 25] . In addition, ARFGAP1 has been shown to regulate AP-2-dependent endocytosis through the binding of adaptor proteins [26] as well as LRRK2 linked to sporadic and autosomal dominant forms of Parkinson's disease [27, 28] . In this study, we show that ARFGAP1 is present on lipid droplets and that it appears important for lipid droplet formation. Lipid droplet association of ARFGAP1 is observed transiently in cultured cells and at steady state in some but not all hepatocytes of human liver tissue.
Results

Overexpression or knockdown of ARFGAP1 affect lipid droplet size and numbers
In previous work examining the role of ARFGAP in vesicle budding and scission in the Golgi apparatus of HeLa cells [20] , we noted that upon high over-expression, ARFGAP1 fused to enhanced yellow fluorescence protein (ARFGAP1 YFP ) localized to ring-like structures suggestive of lipid droplets (Fig. 1A , upper right panel) rather than the Golgi apparatus (Fig. 1A , upper left panel). Some over-expressing cells also revealed an intermediate pattern with some ring-like structures positive for ARFGAP1 YFP in addition to the juxta-nuclear Golgi apparatus (Fig. 1A , upper middle panel). When examined at the ultra structural level, lipid droplet-like structures were observed surrounded by extensive vesicular/tubular profiles (Fig. 1A , lower panels). Overexpression of ARFGAP1 is known to affect the integrity of the Golgi apparatus resulting in a brefeldin A-like phenotype [29] and it is possible that observed vesicular/tubular profiles correspond to Golgi remnants. Another possibility is that such vesicular/tubular profiles represent smaller lipid droplets and that ARFGAP1 is engaged in trafficking between such smaller lipid droplets and larger ones. ARFGAP1
YFP fluorescence was observed both adjacent to and around lipid droplet-like structures (see also Figure S1 detailing the movement of ARFGAP1 YFP fluorescent structures over the course of 40 minutes). To confirm that observed structures were lipid-based, we transfected plasmid DNA encoding ARFGAP1 YFP into cultured HepG2 human hepatoma cells and counter-stained with Bodipy 558/568 C 12 to stain neutral lipids. As can be seen in the upper and lower middle panels of Figure 1B and We next examined whether knockdown of endogenous ARFGAP1 affects lipid droplet formation in HepG2 cells. siRNA specific for endogenous ARFGAP1 causing knockdown (KD) or siRNA composed of a scrambled sequence serving as a mock (M) control were transfected into HepG2 cells. At 24 hours post transfection, cells were incubated with oleate (final concentration at 0.5 mM) for either 1 or 4 hours. After exposure to oleate, cells were fixed and processed for indirect immunofluorescence using an antibody specific to ARFGAP1 [30] . In mock transfected cells incubated with oleate for 1 hour, this antibody gave rise to a juxta nuclear ribbon-like structure consistent with the Golgi apparatus ( Fig. 2A , upper left panel) whilst in cells transfected with siRNA specific for ARFGAP1, only weak staining was observed consistent with knockdown of ARFGAP1. Under these conditions, lipid structures staining positive for Bodipy 493/503 decreased both in area per cell and number per cell (Fig. 2 C) . Total area of Bodipystaining of lipid droplets in each cell as well as the number of stained lipid droplets per cell was quantified in 150 cells per experiment in five independent experiments using ImageJ 1.45 s (see Image Analysis in Materials and Methods). About a 60% and 45% reduction in the area and number of Bodipy positive structures were observed upon knockdown of ARFGAP1, respectively (Fig. 2C) . The difference between mock transfected cells and cells transfected with siRNA specific for ARFGAP1 was less pronounced after 4 hours of incubation with oleate with respect to number of observed droplet-like structures staining positive for Bodipy ( Figure 2B ). Instead, we observed a significant decrease in size of lipid droplets produced in cells where ARFGAP1 expression had been diminished (compare the two lower panels of Fig. 2B ). In addition, we noted in mock transfected cells after 4 hours of incubation of oleate, that there was an apparent increase in cytoplasmic staining of endogenous ARF-GAP1 (Fig. 2B upper left panel) in close proximity to structures staining positive for Bodipy. That siRNA specific for ARFGAP1 caused knockdown of endogenous ARFGAP1 was further examined by western blotting. Figure 2D shows that cells transfected with siRNA specific for ARFGAP1 to cause knockdown (KD) have a marked decrease in the antibody-generated reaction product specific for ARFGAP1 compared to that of mock (M) transfected cells. The ER-resident chaperone calnexin was monitored as a control using an antibody specific for its cytoplasmic domain [31] . Thus, decreased staining of ARFGAP1 as deduced by indirect immunofluorescence and western blotting suggest that the majority of ARFGAP1 had been knocked down. We conclude from this that lowering expression of endogenous ARFGAP1 affects lipid droplet formation. Also, that exposure to oleate for 4 hours affects localization of ARFGAP1.
ARFGAP1 is transiently recruited to lipid droplets in HepG2 cells upon addition of oleate
To investigate the localization of ARFGAP1 upon oleate addition more precisely; we fixed and processed HepG2 cells for indirect immunofluorescence both before and 4 hours after addition of 0.5 mM oleate (final concentration). As shown in Figure 3 (upper panels), there was no apparent co-localization between endogenous ARFGAP1 and structures staining positive for Bodipy before addition of oleate. In contrast, after 4 hours of incubation with oleate, most of the ARFGAP1 staining was seen surrounding Bodipy-positive lipid droplets ( Fig. 3 lower panels) . The staining for ARFGAP1 was compared with a known lipid droplet marker, PLIN3 (Perilipin 3/TIP47) which has also been implicated in Golgi/endosomal trafficking [32] . As shown in Figure 4 and in the enlarged region of interest (ROI), there was considerable co-localization (yellow) between ARFGAP1 (red) and PLIN3 (green). This shows that ARFGAP1 localizes to lipid droplet structures 4 hours after oleate addition partly overlapping with PLIN3. As ARFGAP1 was first identified as an activator protein for the small GTPase ARF1 in the context of coat regulation of COPI coatomer responsible for the generation of COPI transport vesicles and retrograde transport in the Golgi apparatus (for review, see [32] ), it was of further interest to test whether these and other Golgi markers also localized to lipid droplet structures upon addition of oleate. Figure 5 row of upper panels show the distribution of COPB1 (bCOP), a component of the 7 subunit coatomer complex as revealed by the mouse monoclonal antibody CM1A10 specific for one of its components [33] before (-OA) and 4 hours after addition of oleate (4 hr OA). Most staining forCOPB1 appeared as juxta nuclear Golgi staining with additional punctate staining throughout the cytoplasm, a staining pattern typical of coatomer. No apparent co-localization with lipid droplets was observed under these conditions. ARF1 was probed for in the hepatoma cell line, McA-RH7777 using a rabbit polyclonal (Fig. 5, aARF1 ) [30] resulting in a predominant juxta nuclear Golgi staining with occasional small punctate structures throughout the cytoplasm of cells before addition of oleate. At 4 hours after addition of oleate, staining remained predominantly juxta nuclear with an increase in staining of cytoplasmic structures. A minor portion of such cytoplasmic structures appeared close to lipid droplets as revealed by Bodipy stain. It is likely that the antibody used here recognizes additional ARFs due to their close homology. From above experiments, it appears that ARFGAP1 distributes to lipid droplets upon addition of oleate whereas coatomer and most of ARF1 do not. At 4 hours after addition of oleate, the Golgi apparatus appears intact. This was confirmed in HepG2 cells using an antibody to TMED7 (gp27) (Fig. 5 , aTMED7), a member of the gp25L/emp24 family of small transmembrane proteins of the early secretory pathway [34] .
Exclusive juxta nuclear Golgi staining was observed before and 4 hours after addition of oleate. An antibody to the cytoplasmic domain of CANX (calnexin) was used to test for changes of the ER in HepG2 cells 4 hours after addition of oleate. No discernable difference was observed (Fig 5, aCANX) . This shows that the gross architecture of the Golgi apparatus or the ER is not affected at 4 hours after addition of oleate despite loss of ARFGAP1 to lipid droplets. To investigate when ARFGAP1 redistributes to lipid droplet structures, McA-RH7777 cells were incubated with oleate for various lengths of time (Fig. 6 ). This revealed that though most of ARFGAP1 localized to lipid droplets 4 hours after addition of oleate, much less was observed at later time points suggesting a transient association. At 10 hours after oleate addition, over half of ARFGAP1 still remained associated with lipid droplet structures whereas after 24 hours, ARFGAP1 was exclusively located at the juxta nuclear Golgi area. The shift in distribution of endogenous ARFGAP1 from the Golgi apparatus to lipid droplets was quantified 4 hours after addition of oleate in 350 cells per experiment in 5 independent experiments using ImageJ 1.45 s software (see Materials and Methods). In HepG2 and McA-RH7777 cells, the percentage of cells that had ARFGAP1 associated with lipid droplets increased from 0% to 80% and 0% to 75% at 4 hours after addition of oleate, respectively ( Fig. 7-left) . About 65% and 50% of Bodipy-stained structures were associated with ARFGAP1 per cell at 4 hours after oleate addition in HepG2 and McA-RH7777 cells, respectively (Fig. 7, middle) . Addition of oleate caused a marked increase in the area of Bodipypositive lipid droplets corresponding to a 10 and 5 fold increase in HepG2 and McA-RH7777 cells, respectively (Fig. 7, right) . To confirm that ARFGAP1 indeed localizes to lipid droplets upon addition of oleate, HepG2 cells were fixed and processed for immuno-gold transmission electron microscopy (see Materials and Methods). Figure 8 shows single antigen gold-labeled thin frozen sections after 4 hours incubation with oleate incubated with a control antibody (MOCK), a goat polyclonal antibody to ADRP (PLIN2), a lipid droplet marker, or a rabbit polyclonal antibody to ARFGAP1 [30] . Arrowheads in black and white point to gold particles detected revealing staining at the periphery of lipid droplets of both ADRP and ARFGAP1. On occasion, gold particles for ADRP were detected also within the lipid droplet structure. Cells were then fixed 1 hour or 4 hours after addition of oleate and stained to reveal endogenous ARFGAP1 (red) and lipid droplets (green) using a rabbit polyclonal to ARFGAP1 and Bodipy 493/503, respectively. Bars = 5mm. In C, left, lipid droplets per cell were quantified as total area of Bodipy493/503 stained droplets per cell expressed as a percentage of the total area of Bodipy493/503 stained droplets in cells transfected with siRNA specific to ARFGAP1 compared to Mock transfected cells. In C, right, the number of Bodipy493/503 stained lipid droplets per cell was compared between cells transfected with siRNA specific to ARFGAP1 and Mock-transfected cells. P-values were obtained using the Mann-Whitney rank sum test comparing the number (P,0.001) or average size (P,0.001) of Bodipy-stained lipid droplets in Mock transfected cells with those of transfected cells. In D, western blots of ARFGAP1 and calnexin. Extracts from cells transfected either with scrambled siRNA (Mock, M) or siRNA specific to ARFGAP1 for knockdown (KD) were subjected to SDS-PAGE, transfer to PVDF membranes and blotted against ARFGAP1 and Calnexin using specific antibodies. doi:10.1371/journal.pone.0111309.g002 ARFGAP1 Is Associated with Lipid Droplets PLOS ONE | www.plosone.orgLipid droplet association of ARFGAP1 is reversed upon addition of cAMP Based on above data, it appears that most if not all ARFGAP1 associates transiently with lipid droplets peaking at 4 hours after addition of oleate. Such transient association suggests a dynamic recruitment of ARFGAP1 to lipid droplets upon oleate uptake, possibly regulated by cAMP effector proteins such as cAMPdependent protein kinase (PKA) shown to affect lipid homeostasis [35] . To test this, McA-RH7777 cells were incubated in the presence of oleate for 4 hours (Fig. 9 ) followed by addition of cAMP. Before addition of cAMP, most if not all of endogenous ARFGAP1 localized to peri-lipid droplet structures positive for Bodipy (Fig. 9 upper panels) . As above, no discernable juxta nuclear Golgi staining was observed. At 10 minutes after cAMP addition, staining for endogenous ARFGAP1 was detected in the juxta nuclear Golgi region as well as around lipid droplet structures (Fig. 9-middle panels) . At 30 minutes after cAMP addition, staining for endogenous ARFGAP1 was mainly detected in the juxta nuclear Golgi apparatus with some staining remaining around lipid droplet structures. At these time points (10 and 30 minutes), no discernable decrease in the overall amount of lipid droplets was observed (Fig. 9 ).
ARFGAP1 associates with lipid droplets in human liver
Though it appears that ARFGAP1 localizes transiently to lipid droplets structures at 4 hours after addition of oleate in both McA-RH7777 and HepG2, it was important to rule out that such a shift in steady state distribution reflects an unphysiological condition induced by a sudden influx of oleate. We therefore examined ARFGAP1 in human hepatic tissue. Thin frozen sections were generated from liver tissue resected from patients undergoing surgery for removal of metastases of the liver as well as from donor livers obtained through Transplant Quebec (http:// transplantquebec.ca/en) (see Materials and Methods) and subjected to indirect immunofluorescence. Figure 10A shows a frozen section stained for endogenous ARFGAP1 (aARFGAP1, left panel), DAPI to reveal nuclear chromatin (middle panel) and Bodipy 493/503 to stain for neutral lipids (right panel). Some of the staining for ARFGAP1 decorates what appear to be large lipid droplet structures often comparable or larger in size than the nucleus. In this section, ARFGAP1 is seen both as a compact Golgi-like staining as well as decorating lipid droplet-like structures (arrowheads). The staining of endogenous ARFGAP1 was also compared with the lipid droplet marker protein PLIN3 and Bodipy 493/503 to stain for neutral lipids (Fig. 10B-right panel) . Note that staining of endogenous ARFGAP1 (Fig. 10B-left panel) mostly but not fully overlap with that of PLIN3 (Fig. 10B-right  panel) . In liver sections examined, overlapping staining between ARFGAP1 and PLIN3 approached 60% based on 138 lipid droplets. However, the appearance of ARFGAP1 on lipid droplet structures in a given liver section is not uniform nor is the overall frequency of ARFGAP1 positive lipid droplet structures when compared between livers of different patients/donors. Nevertheless, the appearance of ARFGAP1 on lipid droplet structures suggests a physiological relevance prompting further studies.
Discussion
Previous proteomics data has included ARFGAP1 as a potential lipid droplet-associated protein under conditions where GTP hydrolysis was inhibited through addition of the non-hydrolyzable GTP analogue, GTPcS [36] . More recent data based on interference RNA-based experiments suggests that ARFGAPs 1-3 promote lipid droplet formation in HeLa cells [37] . In that study, similar effects were also observed upon knockdown of COPB1, GBF1 and class II ARFs (ARF4 and ARF5). The authors further concluded, based on indirect immunofluorescence data, that COPB1, GBF1, ARF4 and ARFGAP1 do not associate with lipid droplets, at steady state [37] . This is in contrast to recent studies suggesting a role for COPI components in establishing/maintaining interconnections between lipid droplets and the ER as well as in the formation of vesicles budding of the surface of the lipid droplet [4, 5] . Our study shows that ARFGAP1 associates transiently with lipid droplets in cultured hepatoma cells (HepG2 and McA-RH7777) upon addition of oleate and at steady state on lipid droplets of some but not all hepatocytes of human liver. Indirect immunofluorescence staining of endogenous ARFGAP1 or fluorescence from expressed ARFGAP1 YFP is clearly visible as peri-droplet staining but also on adjacent juxta-posed structures. Though immuno-gold labeling of ARFGAP1 show gold particles decorating the perimeter of the lipid droplet, we cannot formally rule out that such gold particles label ARFGAP1 on structures that reside very close to the surface of the lipid droplet (the combined size of primary and secondary antibodies gives rise to an uncertainty in distance of up to 30nm between the antigen and the gold particle).
Based on the evidence at hand, we suggest that ARFGAP1 association with lipid droplets of hepatocytes of human liver indicates a physiological and functional context between ARF-GAP1 and lipid droplets. Indeed, over expression of ARFGAP1 promotes lipid droplet formation in both HeLa and HepG2 cells whereas knockdown experiments of ARFAGP1 impair lipid droplet formation in both HepG2 and McA-RH7777 cells. It is possible that over-expression of ARFGAP1 causes cellular stress and that stress in turn promotes lipid droplet formation [38] independent from ARFGAP1 function. Such stress could either be through its catalytic activity or lipid-binding properties. As such, we interpret our over-expression results with caution. It is further possible that knockdown experiments cause cellular stress. However, the phenotype is here the opposite in that knockdown of ARFGAP1 impairs lipid droplet formation. As components of the COPI machinery have been linked to lipid droplet biogenesis, the phenotype observed may be explained through an impaired Golgi-derived delivery of components needed for lipid droplet formation [1] [2] [3] , maintenance of LD-ER connections and/or formation of lipid-droplet derived vesicles [4, 5] . It is further possible that addition of oleate results in cellular stress and that this prompts a transient relocation of ARFGAP1 to lipid droplets. However, even though relocation is transient, addition of cyclic AMP reverses ARFGAP1 back to the Golgi apparatus indicating and underlying physiological process. This is supported by the observation that ARFGAP1 localizes to lipid droplets at steady state in some but not all hepatocytes of human livers. As these livers all have varying degrees of steatosis, it will be of interest in the future to determine whether ARFGAP1 localization to lipid droplets correlates with certain pathophysiological states. In conclusion, we have demonstrated that ARFGAP1 associates transiently or at steady state with lipid droplets and to structures in close juxtaposition to lipid droplets in cell culture and human liver tissue, respectively, and that ARFGAP1 affects lipid droplet formation. The physiological context as to why ARFGAP1 is present on lipid droplets remains to be determined. As ARFGAP1 is historically linked to COPI vesicle function by serving as an activating protein for ARF1 in the recruitment of coatomer as well as in the scission of vesicles, an involvement in COPI function at the level of lipid droplet biogenesis and homeostasis is possible [4, 5] . Other putative functions include binding to SNARE proteins present on lipid droplets involved in membrane fusion [39] or in the regulation of motility of lipid droplets through ARF1 [40] . It is also conceivable that ARFGAP1 acts on ARF1 in the recruitment of phospholipid-modifying enzymes [13] [14] [15] or PLIN2 [18, 19] to the surface of lipid droplets or that its presence on lipid droplets signifies a function yet to be determined.
Materials and Methods
Chemicals and Reagents
Phosphate buffered saline (PBS), Tween (0.05%), oleate, 8-Bromoadenosine-39, 59-cyclic monophosphate (c-AMP) sodium salt, Nile red stain, Coomassie Brilliant Blue G, sodium fluoride, EDTA, Tris-HCl, sucrose, tricine, NaCl, Na 2 HPO 4 , KH 2 PO 4 , CaCl 2 , MgCL 2 , Tween 20, Fish skin gelatin, Saponin, PFA, Mowiol, ammonium choride, lead citrate, bromophenol blue, Biomax X-Omat XAR or MR films from Eastman Kodak, 10 nm colloidal gold-affinity purified rabbit anti-Goat, ACN, gelatin, formic acid, and sodium citrate were all from Sigma-Aldrich (Oakville, Ontario, Canada). Acetone, PVDF, KCl, water (LCMS grade), DMSO and trypsin were from Fisher Scientific (Quebec, Canada). FuGENE HD Transfection Reagent, SDS and Tris base were from Roche Ltd (Laval, Qc, Canada). Sodium cacodylate and Epon 812 were from Mecalab Ltd (Quebec, Canada). DTT was from Biomol (Hamburg, Germany). ECL detection kit was from GE Healthcare (Baie d'Urfe, Quebec, Canada). Thirty percent (wt/vol) acrylamide/0.8% (wt/vol) bis-acrylamide solution was from Bio-Rad (Mississauga, On. Canada). Uranyl acetate, glutaraldehyde, and glycerol were from Merck (Kirkland, Qc, Canada). Osmium tetroxide was from Agar Scientific (Essex, United Kingdom). Laemmli 2 X from Bio-Rad (Ontario, Canada). ProLong Gold Antifade, MEM, GIBCO DMEM, FBS, penicillin streptomyocin, Bodipy 493/503, Bodipy 558/568 C12, glutamine, Lipofectamine siRNA was purchased from Invitrogen (Carlsbad, CA). 12 nm colloidal gold-affiniPure Goat anti-Rabbit IgG (H+L) was purchased from Cedar Lane laboratories (Ontario, Canada). ARFGAP1-EYFP was kindly supplied by Dr. J. LippincottSchwartz (National Institutes of Health, Bethesda, MD). The mouse monoclonal antibody CMIA10 against COPB1 and rabbit polyclonal antibodies to ARFGAP1 ARF1, TMED7 and Calnexin have all been described previously [10, 30, 33, 34, 41] . Goat polyclonal antibodies to PLIN3 (Tip47) and PLIN2 (ADRP) were purchased from Santa Cruz Biotechnologies Inc (Santa Cruz, Ca, USA). AlexaFluor 488 and AlexaFluor 568 secondary antibodies were purchased from Invitrogen (Carlsbad, CA). HRP-labeled polyclonal antibodies to rabbit IgG were purchased from Dianova (Hamburg, Germany). Protein A-HRP conjugate was purchased from Bio-Rad (Ontario, Canada).
Indirect immunofluorescence and confocal microscopy
HeLa, McA-RH7777 and HepG2 cells were grown in DMEM supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml). Lipid droplet formation was induced by adding 0.5 mM oleate (from 100 mM stock in ethanol) directly to media. In selected experiments, Bodipy 558/568 C 12 was added at the same time as oleate to a final concentration of 3 mM in order to stain newly forming lipid droplets. cAMP was added cells to a final concentration of 37.5 mg/ml. Cells were processed for indirect immunofluorescence as described previously [34] . Post staining of neutral lipid droplets using 1 mg/ml Bodipy 493/503 was performed as described in [42] . All images were acquired using a LSM 700 series microscopy system (Carl Zeiss) fitted with a Plan-Apochromat 63x/1.40 Oil DIC objective in sequential scanning mode with the pinhole set to obtain an optical section of about 0.8 mm in both channels (approximately 1 Airy unit). For Alexa 488 and Bodipy 493/503, a 488 nm Argon ion laser was used and emitted fluorescence was filtered through a 505 to 530 nm band-pass. Bodipy 558/568 C 12 and Alexa 568 was excited with a 561 nm DPSS laser and emitted fluorescence was filtered through a 585 to 690 nm band-pass. Tissue cryosections (see below) were cut from isopentane frozen tissue cubes at a thickness of approximately 6 microns and air dried for an hour then fixed in 4% paraformaldehyde solution for 30 minutes. Subsequent indirect immunofluorescence was performed as above. For live cell imaging, cells were grown and imaged as above in MatTek dishes (MatTek Corporation, Ashland, MA, USA) and imaged as above under normal tissue culture conditions (i.e. CO 2 , humidity and temperature). Prior to live cell imaging, cells were transfected with FuGENE HD according to manufacturers instructions (Roche Ltd, Laval, QC, Canada). EYFP was excited using a 512 nm laser line from an Argon ion laser and emission was filtered through an LP535 band-pass.
siRNA transfection, lipid droplet staining and western blotting RNA oligos were transfected with the siRNAMAX transfection reagent according to manufacturer instructions (Invitrogen, Carlsbad, CA). ARFGAP1 was knocked down using a sequence previously published [20, 43] . A scrambled sequence was used as a negative control. At 24 hours post transfection, cells were incubated with 0.5 mM oleate for 1 or 4 hours or left untreated. Cells were then fixed, imaged and processed as above. Lipid droplets were stained with Bodipy 493/503 (1 mg/ml) for 30 minutes. Western blotting was carried out as described previously [30] .
Image Analysis
Fluorescence levels were coded with a gray scale representing pixel intensity of 25-255. For semi-quantitation, in all cases background (pixel values outside the cells) was relatively low (, 10% of the signal). Therefore, to minimize data manipulation, background subtraction was not performed. All images were processed and analyzed with ImageJ 1.45 s (National Institutes of Health, USA), where the mean intensities of the Golgi region and lipid images were measured to quantify the lipid droplets and the ARFGAP1 associated with the lipid droplets in each cell in the field of view. Quantitation of fluorescence was made from 150 to 350 cells for each experiment (10 sites/slide). Each experiment was performed at least three times. For quantification, images of HeLa, McA-RH7777 or HepG2 cells were processed with a binary segmentation algorithm. Briefly, after a sharpening, brightness/ contrast adjustment (equal values for all images) and find edges, an Otsu's method thresholding step was run to automatically perform a reduction of a gray level image to a binary image. Watershed processing to identify solitary particles followed. Finally, lipid droplets (Bodipy 493/503 or 558/568) or Golgi region (TMED7 or ARFGAP1) were identified with the generic ''analyze particles'' function of the ImageJ software with the following settings: for the Golgi apparatus size from 100 to 10,000 pixels; and for the lipid droplets size from 1 to 2500 pixels and circularity from zero to one (final values were expressed in physical size square units); outlines as well as measurement results displayed and measurements on the edges excluded. The summary of the results was done through the 'ROI' (Region Of Interest) Manager that is a tool for working with multiple selections where areas to be evaluated can be specified editing out unwanted elements. For each image, the average particle size and cumulative measured area for all particles (''area'') were reported. The obtained information was used to calculate the ratio of lipid droplets per cells as a measure of lipid storage (''number of Bodipy-stained droplet/cell'' or ''of total area Bodipy-stained droplet/cell'') or ARFGAP1 associated with lipid droplets. All data were imported into Sigma Plot (SPSS Inc.). The Mann-Whitney rank sum test was used for statistical analysis. A P value of less than 0.05 was considered to be significant.
Transmission electron microscopy
HeLa cells were fixed using a double fixation protocol with osmium and tannic acid [44] . Samples were dehydrated in graded ethanol series, and embedded in Epon 812 (Serva). After 48 h at 60uC, ultra-thin sections (60 nm) were cut and mounted on grids. Samples were examined on a LEO 912 OMEGA (Energy Filter Transmission Electron Microscope, Zeiss) at 120 kV accelerating voltage. Digital images were obtained through a side-mounted MegaView III TEM CCD camera.
Immuno-gold transmission electron microscopy
Cryosections were prepared using an adaptation of the standard protocol developed by Tokuyasu [45] . Cells were fixed with a mix of 4% Formaldehyde and 0.1% Glutaraldehyde for 2 hours at 4uC and washed twice with PBS. A small volume of 1% gelatin in PBS was then added after which cells were removed from the dish using a rubber policeman cell scraper and transferred to a 1.5 ml Eppendorf tube and centrifuged for 30-60 sec at 1500 rpm. The 1% gelatin was then replaced with a 10% gelatin solution at 37uC. Cells were then resuspended and centrifuged as above after which excess gelatin was removed. Cells in gelatin were then solidified on ice for 30 minutes. At 4uC, the bottom of the Eppendorf tube was then cut off and 1-mm gelatin blocks were prepared from the pellet and incubated end over end in phosphate buffered 2.3 M sucrose overnight at 4uC. After trimming, ultrathin sections (75 nm) were prepared at 2120uC. Sections were immediately transferred to a 1:1 mixture of 2% methylcellulose and 2.3 M sucrose [46] and 2 ml of 4% uranyle acetate, and transferred to copper grids bearing a carbon-coated Formvar supporting film. Labeling was carried out at room temperature using specific antibodies and gold conjugates diluted in 0.5% fish skin gelatin in PBS. 10 nm colloidal gold-affiniPure Rabbit anti-Goat and 12 nm colloidal gold-affiniPure Goat anti-Rabbit IgG (H+L) were used to detect primary polyclonal antibodies. Sections were then embedded in a thin layer of 2% methylcellulose with 0.4% uranyl acetate, pH 4.0, air-dried, examined and photographed using a Philips/FEI Tecnai12 120 kV Transmission Electron Microscope equipped with an AMT XR80C CCD camera system.
Processing of human liver tissue
Donor material was obtained through Transplant Quebec (http://transplantquebec.ca/en) and healthy resected liver material from patients undergoing liver surgery to remove liver metastasis. For resected material, removed tissue was immediately perfused with ice-cold Wisconsin solution, and within 30 minutes on ice, inspected by an on site pathologist, then processed for biobanking. For donor material, liver slices from discarded livers were perfused using ice-cold Wisconsin solution then processed for biobanking. For biobanking, liver tissue was diced into smaller pieces and placed for 5 minutes in isopentane precooled to 245uC in order to preserve morphology. Samples were then wrapped in tinfoil and kept frozen at 245uC until sectioned.
Ethics statement
All handling and use of human patient and donor material was performed under IRB ethics approved protocols: "Liver DiseaseBiobank" # 11-066-SDR and ''Human Hepatic Tissue Organellar Isolation and Characterization" # 11-196-SDR filed at the McGill University Health Centre, Montreal, Canada in the name of Dr. Peter Metrakos. Patient and donor consent was obtained in written form for all human samples collected. 
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